Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday

Benzinga10-14

With U.S. stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Karooooo Ltd. (NASDAQ:KARO) to report quarterly earnings at 39 cents per share on revenue of $63.23 million after the closing bell, according to data from Benzinga Pro. Karooooo shares gained 14.4% to $50.00 in after-hours trading.
  • Innate Pharma S.A. (NASDAQ:IPHA) named Jonathan Dickinson as its new Chief Executive Officer, effective Nov. 1. Innate Pharma shares gained 5.6% to close at $2.07 on Friday.
  • Nurix Therapeutics, Inc. (NASDAQ:NRIX) reported better-than-expected third-quarter earnings results. The company reported a quarterly loss of 67 cents per share which beat the analyst consensus estimate of a loss of 70 cents per share. Nurix Therapeutics gained 2% to $24.10 in the after-hours trading session.

Check out our premarket coverage here

  • The Boeing Company (NYSE:BA) reported a preliminary loss of $9.97 per share and revenue of $17.8 billion for the third quarter. The company also announced a 10% reduction in its workforce. Boeing shares fell 0.9% to $149.60 in the after-hours trading session.
  • China Liberal Education Holdings Limited (NASDAQ:CLEU) reported a first-half loss of $2.04 per share, compared to year-ago earnings of 18 cents per share. The company reported $890.00 thousand in sales for the quarter. China Liberal Education shares fell 2.8% to $0.2965 in the after-hours trading session.

Check This Out:

  • CVS Has ‘Real Value,’ Jim Cramer Says: Micron Had An ‘Amazing’ Quarter

Photo courtesy: Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment